
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Preclinical Pharmacology |
Laboratory of Experimental Therapeutics [S-H. P., Y. M. C., Y. D. Y.] and Department of Otolaryngology [Y-S. L.], Korea Cancer Center Hospital, Seoul 139-706; Department of Internal Medicine, Yonsei University College of Medicine, Seoul 135-720 [H. J. K.]; Department of Internal Medicine, Korea University Guro Hospital, Seoul 152-050 [J. S. K.]; and Department of Biology, Chonnam National University, Kwangju 500-757 [H. Z. C.], Korea
Human peroxiredoxin II (Prx II) has been known to function as an
antioxidant enzyme in cells. Using head-and-neck cancer cell lines, we
investigated whether Prx II expression is related to the resistance of
cells to radiation therapy in vivo and in
vitro, and whether a Prx II antisense serves as a
radiosensitizer. Increased expression of Prx II was observed in tissues
isolated from the patients who did not respond to radiation therapy,
whereas Prx II expression was weak in tissues from the patients with
regressed tumors. Enhanced expression of Prx II in UMSCC-11A (11A)
cells was also observed after treatment with
radiation. This
increased expression conferred radiation resistance to cancer cells
because overexpression of Prx II protected 11A cells from
radiation-induced cell death, suggesting that blocking Prx II
expression could enhance radiation sensitivity. Treatment of 11A cells
with a Prx II antisense decreased induction of Prx II, enhancing the
radiation sensitivity. From these results, we suggest that
stress-induced overexpression of Prx II increases radiation resistance
via protection of cancer cells from radiation-induced oxidative
cytolysis and that a Prx II antisense can be used as a radiosensitizer.
This article has been cited by other articles:
![]() |
J.-H. Kim, P. N. Bogner, S.-H. Baek, N. Ramnath, P. Liang, H.-R. Kim, C. Andrews, and Y.-M. Park Up-Regulation of Peroxiredoxin 1 in Lung Cancer and Its Implication as a Prognostic and Therapeutic Target Clin. Cancer Res., April 15, 2008; 14(8): 2326 - 2333. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Iraqui, G. Faye, S. Ragu, A. Masurel-Heneman, R. D. Kolodner, and M.-E. Huang Human Peroxiredoxin PrxI Is an Orthologue of Yeast Tsa1, Capable of Suppressing Genome Instability in Saccharomyces cerevisiae Cancer Res., February 15, 2008; 68(4): 1055 - 1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Lee, K.-S. Choi, J. Riddell, C. Ip, D. Ghosh, J.-H. Park, and Y.-M. Park Human Peroxiredoxin 1 and 2 Are Not Duplicate Proteins: THE UNIQUE PRESENCE OF CYS83 IN Prx1 UNDERSCORES THE STRUCTURAL AND FUNCTIONAL DIFFERENCES BETWEEN Prx1 AND Prx2 J. Biol. Chem., July 27, 2007; 282(30): 22011 - 22022. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Monteiro, B. B. Horta, D. C. Pimenta, O. Augusto, and L. E. S. Netto Reduction of 1-Cys peroxiredoxins by ascorbate changes the thiol-specific antioxidant paradigm, revealing another function of vitamin C PNAS, March 20, 2007; 104(12): 4886 - 4891. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Okamoto, J. Li, A. O. Vortmeyer, H. Jaffe, Y.-S. Lee, S. Glasker, T.-S. Sohn, W. Zeng, B. Ikejiri, M. A. Proescholdt, et al. Comparative proteomic profiles of meningioma subtypes. Cancer Res., October 15, 2006; 66(20): 10199 - 10204. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wang, D. Tamae, T. LeBon, J. E. Shively, Y. Yen, and J. J. Li The Role of Peroxiredoxin II in Radiation-Resistant MCF-7 Breast Cancer Cells Cancer Res., November 15, 2005; 65(22): 10338 - 10346. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. A. Wood, L. B. Poole, and P. A. Karplus Peroxiredoxin Evolution and the Regulation of Hydrogen Peroxide Signaling Science, April 25, 2003; 300(5619): 650 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yang, D. A. Maiguel, and F. Carrier Identification of nucleolin and nucleophosmin as genotoxic stress-responsive RNA-binding proteins Nucleic Acids Res., May 15, 2002; 30(10): 2251 - 2260. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |